Episode
Highlights vom ERA 2025 in Wien
- Published
- Jul 16, 2025
- Duration seconds
- 1794
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/stethoskop-medizin-zum-nachh-ren-6646024/episodes/highlights-vom-era-2025-in-wien/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/stethoskop-medizin-zum-nachh-ren-6646024/highlights-vom-era-2025-in-wien.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr. Marcus Säemann präsentiert seine Highlights vom ERA 2025 in Wien. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes https://www.nejm.org/doi/abs/10.1056/NEJMoa2410659 Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes https://www.nejm.org/doi/full/10.1056/NEJMoa2501006 ARO-C3, an investigational RNAi Therapeutic Targeting Complement C3, Reduces Proteinuria, Hematuria, andComplement Activity in IgAN Patients https://ir.arrowheadpharma.com/...